Annals of Neurology · 2004 · 213 citations · 16 references
Life SciencesNeurologyPharmacotherapyDisability ManagementImmunotherapyNeuroimmunologyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisDisability Status AnalysisDisability Status Determination
In 2001, we followed up all patients from the 1991 Olmsted County Multiple Sclerosis (MS) prevalence cohort. We found that the longer the duration of MS and the lower the disability, the more likely a patient is to remain stable and not progress. This is particularly powerful for patients with benign MS with Expanded Disability Status Scale score of 2 or lower for 10 years or longer who have a greater than 90% chance of remaining stable. This is important because these patients represent 17% of the entire prevalence cohort. These data should assist in the shared therapeutic decision-making process of whether to start immunomodulatory medications.
16
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.9K citations
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Charles M. Poser, Donald W. Paty, Labe C. Scheinberg et al. · Annals of Neurology · 1983 · 7.4K citations
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
The natural history of multiple sclerosis:a geographically based study
David A. Cottrell, Marcelo Kremenchutzky, George P. Rice et al. · Brain · 1999 · 1.2K citations · Full text